Fig. 7From: Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancerSchematic diagram. Regulation of HtrA1 by HDAC and RXR significantly increases the efficacy of cisplatin in NSCLC/CDDP resistant cellsBack to article page